Entering text into the input field will update the search result below

PhaseBio completes campaign for commercial-scale manufacturing runs for bentracimab

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research. Working on Computers, Analyzing Samples

gorodenkoff/iStock via Getty Images

  • PhaseBio Pharma (NASDAQ:PHAS) completed a campaign of commercial scale runs required for validating the manufacturing process for its lead drug candidate bentracimab.
  • The company said the Process Performance Qualification (PPQ) campaign consisted of multiple commercial scale runs required for

Recommended For You

Comments (3)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

Long several thousand shares. And what a long road it’s been. Should be amazing…..someday.
@dynx exactly.......someday.
@philestate up on really strong volume. Hopefully insider trading on news to come.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.